Recent Patents on Anti-Cancer Drug Discovery


Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY

Personal Subscription
Become EABM
Become Reviewer

c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer

Volume:1   Issue: 3
Pp: 305-326
Sam Robson, Stella Pelengaris and Michael Khan
DOI: 10.2174/157489206778776934

Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents

Volume:1   Issue: 3
Pp: 327-346
Stephen J. Ralph, Pauline Low, Langfeng Dong, Alfons Lawen and Jiri Neuzil
DOI: 10.2174/157489206778776952

Inhibition of Cyclin-Dependent Kinases - A Review of the Recent Patent Literature

Volume:1   Issue: 3
Pp: 357-367
Andrea D. Basso and Ronald J. Doll
DOI: 10.2174/157489206778776916

Last Generation of Amino-Bisphosphonates (N-BPs) and Cancer Angiogenesis: A New Role for These Drugs?

Volume:1   Issue: 3
Pp: 383-396
Daniele Santini, Gaia Schiavon, Silvia Angeletti, Bruno Vincenzi, Simona Gasparro, Claudia Grilli, Annalisa La Cesa, Vladimir Virzi, Valentina Leoni, Alfredo Budillon, Santolo R. Addeo, Michele Caraglia, Giordano Dicuonzo and Giuseppe Tonini
DOI: 10.2174/157489206778776989

Bortezomib in the Treatment of Cancer

Volume:1   Issue: 3
Pp: 397-403
Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti
DOI: 10.2174/157489206778776925

Patent Annotations

Volume:1   Issue: 3
Pp: 405-408
Bentham Science Publishers
DOI: 10.2174/157489206778776970

Patent Selections promotion: free to download

Volume:1   Issue: 3
Pp: 409-411
Bentham Science Publishers
DOI: 10.2174/157489206778776943